Quick-Glia™ Astrocytes - Human iPSC-derived Astrocytes Alzheimer's Disease - (F, 68yr, Caucasian, not Latino)

Cryopreserved human iPSC-derived astrocytes from Alzheimer's Disease patient (F, 68)
As low as ¥366,000.00
Our proprietary transcription factor-based stem cell differentiation method produces highly pure populations of astrocytes without a genetic footprint. Quick-Glia™ Astrocytes - Human iPSC-derived Astrocytes display typical astrocyte morphology and markers such as S100 Calcium Binding Protein β (S100β), Chondroitin Sulfate Proteoglycan 8 (CD44), Aldehyde Dehydrogenase 1 Family Member L1 (ALDH1L1), and mature astrocyte marker Glial Fibrillary Acidic Protein (GFAP). When handled and maintained according to the instructions in this user guide, astrocytes are viable long-term and are suitable for a variety of characterization and neurotoxicity assays.
More Information
Short Description Cryopreserved human iPSC-derived astrocytes from Alzheimer's Disease patient (F, 68)
Product Components Cryopreserved cells and Component P
Starting Material iPSCs derived from peripheral blood mononuclear cells (CIRM line CW50169)
Product Use This product is for research use only. It is not approved for use in humans or for therapeutic or diagnostic use.
Storage Conditions Frozen cells should be stored in liquid (vapor phase). The rest of the components should be stored at -20°C.
Cell Type Astrocytes
Culture Type Feeder Cell-Free
Disease Alzheimer's Disease
Donor Sex Female
Donor Race Ethnicity Caucasian, not Latino
Patient History See Resources section for more information.
Reprogramming Method Episomal vector
Induction Method Transcription factors delivered by Sendai virus
Growth Properties Adherent
Shipping Conditions Dry ice (domestic) or liquid nitrogen (international)
Shelf Life 1 year
Donor Age At Sampling 68